- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | ExGen acquires second silver stream on South American gold mine | ||
| Mi | XTL Biopharmaceuticals receives Nasdaq minimum bid price notice | ||
| Mi | Sidus Space closes $25 million public offering of common stock | ||
| Mi | ImmuCell shifts focus to First Defense after FDA setback for Re-Tain | ||
| Mi | Biohaven's depression drug misses primary endpoint in Phase 2 study | ||
| Mi | Agios Pharma stock price target raised to $62 from $48 at H.C. Wainwright | ||
| Mi | Travere Therapeutics stock gains as FDA messaging on proteinuria endpoint boosts Filspari approval hopes | ||
| Mi | 30-year mortgage rate drops to 6.18%, offering holiday relief | ||
| Mi | U.S. regulator issues emergency permit for Sable's Santa Ynez pipeline | ||
| Mi | WORK Medical to implement 1-for-100 reverse stock split | ||
| Mi | Can-Fite BioPharma stock rating downgraded to Hold by D. Boral Capital | ||
| Mi | Comstock Mining stock rating downgraded to Market Perform by Noble Capital | ||
| Mi | Picard Medical secures $50 million private placement financing | ||
| Mi | Visa funds $500m litigation escrow, Baird reiterates Outperform rating | ||
| Mi | WhiteFiber stock price target lowered to $40 at B.Riley on revised EBITDA outlook | ||
| Mi | CompoSecure stock price target raised to $25 from $21 at Lake Street | ||
| Mi | Dave stock price target raised to $308 from $263 at Lake Street | ||
| Mi | ECD Automotive Design receives six orders under new third-party deal | ||
| Mi | Clearmind advances AUD treatment as phase I/IIa trial progresses | ||
| Mi | FDA approves Omeros' Yartemlea for stem cell transplant complication | ||
| Mi | Baird reiterates Outperform rating on Snowflake stock amid acquisition rumors | ||
| Mi | Baker Hughes stock rating reiterated at Outperform by BMO Capital | ||
| Mi | Benchmark raises Huron Consulting Group stock price target to $215 on growth visibility | ||
| Mi | BMO Capital reiterates Market Perform rating on Halliburton stock | ||
| Mi | Keefe, Bruyette & Woods reiterates Outperform rating on Jefferson Capital stock |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .